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Purpose: Beckwith–Wiedemann syndrome (BWS) is a develop-
mental disorder caused by dysregulation of the imprinted gene
cluster of chromosome 11p15.5 and often associated with loss of
methylation (LOM) of the imprinting center 2 (IC2) located in
KCNQ1 intron 10. To unravel the etiological mechanisms under-
lying these epimutations, we searched for genetic variants
associated with IC2 LOM.
Methods: We looked for cases showing the clinical features of
both BWS and long QT syndrome (LQTS), which is often
associated with KCNQ1 variants. Pathogenic variants were
identified by genomic analysis and targeted sequencing. Functional
experiments were performed to link these pathogenic variants to
the imprinting defect.
Results: We found three rare cases in which complete IC2 LOM is
associated with maternal transmission of KCNQ1 variants, two of
which were demonstrated to affect KCNQ1 transcription upstream
of IC2. As a consequence of KCNQ1 haploinsufficiency, these
variants also cause LQTS on both maternal and paternal
transmission.
Conclusion: These results are consistent with the hypothesis that,
similar to what has been demonstrated in mouse, lack of
transcription across IC2 results in failure of methylation establish-
ment in the female germline and BWS later in development, and
also suggest a new link between LQTS and BWS that is important
for genetic counseling.
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INTRODUCTION
KCNQ1 (potassium voltage-gated channel subfamily Q
member 1), the major gene involved in long QT syndrome
(LQTS), is part of the imprinted gene cluster that is associated
with Beckwith–Wiedemann syndrome (BWS, OMIM 130650)
at chromosome 11p15.5.
LQTS (prevalence 1:2000 [ref.1]) is a cardiac arrhythmia
characterized by prolongation of the electrocardiographic
(ECG) QT interval and high risk of syncope, seizures, and
sudden death. The genetic form of this disease is associated
with more than 700 variants in 13 genes encoding ion channel
subunits.2,3 Pathogenic KCNQ1 variants (LQT1, OMIM
192500) represent 35% of LQTS defects and are generally
inherited as isolated cardiac defects within dominant
pedigrees (also known as Romano–Ward syndrome), or in
combination with other clinical features (e.g., deafness) as an
autosomal recessive trait (also known as Jervell and
Lange–Nielsen syndrome).
BWS (prevalence 1:10,500) is a congenital genomic
imprinting disorder, characterized by variable presence of
macroglossia, abdominal wall defects, lateralized overgrowth,
enlarged abdominal organs, and increased risk of developing
embryonal tumors.4,5 Heterogeneous molecular alterations
affect expression of an imprinted gene cluster located at
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11p15.5. The cluster is divided in two domains controlled by
separate imprinting control regions (ICRs). The ICR of the
centromeric domain, known as KCNQ1OT1:transcription
start site (TSS) differentially methylated region (DMR), also
known and herein indicated as imprinting center 2 (IC2), is
located within KCNQ1 intron 10. IC2 corresponds to the
promoter of the long noncoding RNA KCNQ1OT1 and is
methylated and inactive on the maternal chromosome. On the
paternal chromosome, KCNQ1OT1 is transcribed and
represses in cis the flanking imprinted genes, including the
growth inhibitor CDKN1C, which is normally transcribed
from the maternal allele. In 50% of the BWS patients, loss
of methylation (LOM) of IC2 leads to biallelic expression of
KCNQ1OT1 and biallelic silencing of CDKN1C. One-third of
these cases also show methylation abnormalities at other ICRs
(multilocus imprinting disturbances, MLID). Further mole-
cular lesions of BWS are gain of methylation of the H19/IGF2:
intergenic (IG) DMR (5–10%), 11p15 paternal uniparental
isodisomy (20%), loss-of-function pathogenic variants of
CDKN1C (5%), and 11p15.5 copy-number variants (CNVs,
1–4%) (ref. 6). Clinical features, risk of recurrence, and
frequency and histotype of associated tumors differ signifi-
cantly among the main molecular classes of BWS.7
The KCNQ1 gene is 404 kb long, organized in 19 exons, and
harbors two major transcript isoforms arising from alternative
use of promoters: isoform 1 from exon 1a and isoform 2 from
exon 1b. Both isoforms are expressed in heart from both
parental alleles. While isoform 2 is heart-specific, isoform 1 is
expressed in several other tissues and imprinted with the
paternal allele silenced during embryogenesis,8,9 but expressed
from both parental alleles in postnatal tissues including
peripheral blood cells.10
Mouse studies indicate that transcription across ICRs is a
prerequisite for establishing methylation imprints in the
maternal germline.11,12 Because IC2 lies within the transcrip-
tional unit of the KCNQ1 gene, we hypothesized that maternally
inherited pathogenic variants leading to defects of KCNQ1
transcription might also result in loss of maternal IC2
methylation in BWS. We also expect that such pathogenic
variants cause KCNQ1 haploinsufficiency and possibly pro-
longed ECG QTc values and LQTS. To identify such rare cases,
we looked for BWS patients with ECG alterations and IC2 LOM.
We identified three patients who carried maternally inherited
pathogenic variants of KCNQ1. Complete absence of methyla-
tion at the IC2 region was present in all three cases and defective
transcription of the maternal KCNQ1 allele could be demon-
strated in two of them. These results indicate that genetic
variants interfering with transcription across IC2 are associated
with dramatic methylation loss at this region, which is suggestive
of defective establishment of imprint methylation in oocytes and
may evolve into BWS later in embryo development.
MATERIALS AND METHODS
Clinical reports
The proband of family 1 was a Dutch girl born from healthy
and unrelated parents. Her mother became pregnant at
40 years of age. Amniocentesis was performed at 17 weeks of
gestation because of advanced age and ultrasound abnorm-
alities. The fetus showed features typical of BWS, omphalo-
cele, organomegaly, macroglossia, and polyhydramnios.5 The
karyotype showed a balanced paternally derived Robertsonian
translocation 45,XX,der(13;14)(q10;q10). Alpha-fetoprotein
(AFP) was normal (17.6 μg/ml). She was born prematurely
at 33+ 2/7 weeks of gestation with a birth weight of 2565
grams (90th percentile) and length at the 97th percentile.
Clinical diagnosis of BWS was obtained at birth based on the
presence of hypoglycemia, macrosomia, macroglossia, nevus
flammeus, ear creases and pits, and organomegalia.5 Electro-
cardiography showed a prolonged QTc interval of 471 ms
indicative for LQTS.13–15 Molecular diagnosis was obtained by
multiplex ligation-dependent probe amplification (MLPA)
(assays ME-030 and P144 for BWS and LQTS, respectively).
The familial Robertsonian balanced translocation segregated
in this family over five generations and did not have any effect
on the phenotype. At age 18 months she had developed celiac
disease. At 4.5 years, electrocardiography still showed a
prolonged QTc interval (449 ms). At the clinical follow-up at
10 years, besides the BWS characteristics, LQTS, and celiac
disease, she had developed mild bilateral hearing loss.
The proband of family 2 was an American girl born from
unrelated parents. BWS was clinically diagnosed at birth at
the University of Florida Hospital, based on the presence of
omphalocele, macroglossia, and ear pits.5 Molecular diagnosis
of BWS with IC2 LOM was obtained by Southern blot
analysis (Mayo Clinic, Rochester, MN, USA, data not shown).
She also had a history of learning delay and a low-frequency
seizure disorder. At the age of 9 years, an ECG, performed
following an episode of chest pain, revealed prolonged QTc
(492 ms), and LQTS was diagnosed. Asymptomatic LQTS was
diagnosed by ECG in her mother (QTc= 473), who did not
show any sign of BWS. No BWS sign and normal QTc values
were found in her half-sister, maternal grandmother and
maternal grandfather. The maternal aunt, not available to
clinical and molecular analyses, had several miscarriages. The
first fetus, which was aborted at the 20th week, had large
omphalocele, a clinical sign commonly found in BWS
associated with molecular defects of the centromeric
11p15.5 domain. Her only full-term pregnancy was of two
male twins. Of these, one infant was stillborn at scheduled
Cesarean section, while his brother had a heart defect that
required surgery shortly after birth.
The BWS features of family 3, in which segregates a 160-kb
duplication within KCNQ1, were previously reported.16 Two
further family members, healthy cousins of the proband who
were not born at the time of the first study, were added to the
present study. The proband was subjected to ECG within a
screening for LQTS of BWS patients (see below in “ECG to BWS
patients with IC2 LOM” section). Her QTc value was of 478ms
at 7.8 years of age, which is diagnostic of LQTS (Table S1).13–15
Following this finding, ECG was offered to all other carriers of
the duplication of this family. All the individuals examined for
ECG showed borderline prolonged QTc values (mother:
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460 ms at 35 years, maternal uncle: 447 ms at 37 years, cousin:
440 ms at 2 years).
All genetic analyses in this paper were performed after
written informed consent was obtained from the patients or
patients’ parents. All research work has been carried out in
accordance with the ethical principles and the legislation of
Italy, the Netherlands, and the United States. The study was
approved by the Ethical Committee of the University of
Campania “Luigi Vanvitelli” (approval number 1135, 13
October 2016).
ECG to BWS patients with IC2 LOM
Twenty-four patients with clinical and molecular diagnosis of
BWS with IC2 LOM5 were enrolled in an ECG screening. The
patients, aged between 1 month and 24 years, were subjected
to clinical visit, baseline ECG with QTc measurement, and
family history collection. QTc interval was calculated using
Bazett formula.13 QT values are reported in Table S1.
RESULTS
Because the centromeric ICR of the BWS locus is located in
intron 10 of the KCNQ1 gene, which is also associated with
LQTS, we wondered if abnormal QTc values in BWS patients
with IC2 LOM could reveal the presence of pathogenic
variants interfering with the imprinted methylation of this
region. Thus, we looked for the presence of features of LQTS
in BWS patients with IC2 LOM. Three cases were identified
and are described in the following sections.
LQTS and BWS with complete IC2 LOM associated with a
transcription defect of KCNQ1
Unusually low (<5%) IC2 methylation levels were detected in
the family 1 proband (Fig. 1a) by methylation-specific MLPA
(MS-MLPA) (ME-030 kit for BWS/Silver–Russell syndrome
[SRS]) (Fig. 1b) and confirmed by pyrosequencing (Fig. 1c),
indicating absence of the epigenetic mosaicism (10–35%
methylation) found in most BWS patients. Methylation levels
comparable with values of healthy individuals were found at
IC1 and five other ICRs in the proband, and at IC1 and IC2 in
her parents (Fig. 1c and Table S4). MLPA (P144 kit for LQTS)
demonstrated a de novo heterozygous deletion of KCNQ1
exons 1a–1b in the proband (II-1) (Fig. 1d). By typing two
single-nucleotide variants (SNVs; SNV2 and SNV3) falling in
the intron between exon 1a and exon 1b, we demonstrated
that the deletion arose on the maternal chromosome (Fig. 1e).
A comparative genomic hybridization (CGH)-based chro-
mosome array analysis confirmed the presence of the deletion
in heterozygosity and demonstrated that it was 120 kb long
and included the first two KCNQ1 exons, the KCNQ1
promoter, and other three genes (TRPM5, TSSC4, and
CD81). The telomeric breakpoint was mapped between
2,383,764 and 2,397,123, and the centromeric breakpoint
between 2,510,194 and 2,532,843 of chromosome 11, about
30 kb downstream of KCNQ1 exon 1b (reference genome:
hg19. Figure S2). By sequencing the entire coding region, no
additional pathogenic variants were detected, indicating
KCNQ1 haploinsufficiency as the most probable mechanism
of LQTS in the proband.
To investigate the effect of the deletion on KCNQ1 transcrip-
tion, allele-specific expression analysis was performed on total
RNA from peripheral blood leukocytes of the proband.
Consistent with a previous report,10 we observed biallelic KCNQ1
expression in three age-matched healthy individuals (Figure S3).
Transcription was derived from promoter 1a, while promoter
1b–specific transcript was not detected in blood (data not
shown). Significantly, KCNQ1 was expressed from only one
allele in the proband, consistent with the loss of its promoters
on the maternal chromosome (Fig. 1f). These data demon-
strate that a deletion removing both main promoters and
affecting the expression of KCNQ1 is associated with absence
of IC2 methylation on the maternal chromosome.
LQTS and BWS with complete IC2 LOM associated with a
splice-site variant and defective elongation of KCNQ1
transcript
Similar to family 1, low IC2 methylation level (<5%) was
found in the proband (III-1) of family 2 (Fig. 2b). In contrast,
methylation values comparable with healthy controls were
found at IC1 and five other ICRs in the proband and at both
IC1 and IC2 in her mother (II-2) and maternal grandparents
(I-1 and I-2; see Fig. 2b and Table S4). The maternal aunt
(II-3) and her children (III-3 and III-4) were unavailable for
molecular analysis. The molecular cause of LQTS was
investigated by SNV-based chromosomal microarray (CMA)
and targeted sequencing. No clinically relevant CNV was
detected in the proband (data not shown). However, a novel
SNV was identified in heterozygosity at the 5’ donor site of
the first intron of KCNQ1 (KCNQ1-ENST00000155840: c.386
+1G>C [IVS1+1G>C]) (Fig. 2c). This variant was absent in
all available SNV databases (https://www.ncbi.nlm.nih.gov/
projects/SNP; http://www.internationalgenome.org; http://
gnomad.broadinstitute.org; http://exac.broadinstitute.org) and
predicted to be potentially damaging by Human Splicing
Finder (http://www.umd.be/HSF3/). The variant was also
found in heterozygosity in the proband's mother (II-2) and
maternal grandfather (I-1), but absent in her half-sister (III-2)
and maternal grandmother (I-2) (Fig. 2c).
To investigate the functional effect of the splice-site variant,
we determined the transcription profile of KCNQ1 on total
RNA from blood leukocytes of the proband (III-1) and her
half-sister (III-2) by genome RNA sequencing. This analysis
indicated that, although the overall expression of KCNQ1 was
lower in the proband (III-1) than in her half-sister (Figure
S5), the RNA level was not homogeneously distributed along
the KCNQ1 gene in III-1, with the most 5’ 10 kb about two to
threefold more abundant than the rest of the gene, while RNA
level was homogeneously distributed in III-2 (Fig. 3a, b).
Interestingly, a cluster of poly-A addition sites is
present immediately downstream of the position of KCNQ1
intron 1, in which the RNA level declines, suggesting a
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premature termination of transcription in III-1 (Fig. 3a).
Finally, consistent with IC2 LOM, KCNQ1OT1 RNA level
was increased in the proband with respect to her sister
(Fig. 3a).
To confirm the hypothesis of defective KCNQ1 elongation in
the proband, allele-specific expression of KCNQ1 was analyzed
in total RNA from peripheral blood leukocytes, by typing SNVs
present in heterozygosity at different positions of the primary
transcript (Fig. 3c). By typing the intron 1 splice-site variant
(SNV1), we found biallelic KCNQ1 expression in the proband,
as well as in II-2 and I-1 (Fig. 3c, left panels). In contrast,
transcription from only one allele was found in the same
individuals, by typing SNVs in the 3’ part of intron 1 (SNV7,
middle panels) and in the 3’ untranslated region (UTR)
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(SNV15, right panels) of the KCNQ1 gene. III-2 has not
inherited the splice-site variant and therefore was not
informative at this position. However, she showed biallelic
KCNQ1 expression in both intron 1 (SNV9, middle panel) and
3’ UTR (SNV15, right panel). Similarly, KCNQ1 was transcribed
from both parental alleles in intron 1 (SNVs 6–9, middle panel
of Fig. 3c and left panel of Figure S3) and intron 14 (SNVs
13–14, right panels of Fig. 3c and Figure S3) in three age-
matched healthy individuals (Ctrl 1–3) and four further BWS
patients with IC2 LOM (BWS 1–4). To determine the parental
origin of the full-length KCNQ1 RNA in the individuals
carrying the splice-site variant, we typed a SNV (SNV12) of
intron 9 that is present in heterozygosity in the proband and
in homozygosity in her mother (II-2). Only the G allele that is
absent in the mother was amplified from III-2 RNA,
indicating that the splice pathogenic variant is associated
with the defective transcript (Fig. 3d).
To better define the position of the KCNQ1 gene in
which expression shifts from two alleles to one allele in
the individuals carrying the splice-site variant, we typed
two further SNVs (4 and 5) that were located in the 5’ part
of intron 1 (Figure S4). Both SNV4 and SNV5 were
informative in the maternal grandfather (I-1). Expression
was found biallelic at SNV4 but monoallelic at SNV5 in this
individual. Only one allele was transcribed at SNV5 also in the
mother (II-2) and proband (III-1), while both parental alleles
were expressed in two informative healthy individuals (Ctrl 4
and 5). Consistent with the RNAseq data, these results
demonstrated that expression shifts from two alleles to
one allele between 6.6 (SNV4, chr11: 2473311) and 26 kb
(SNV5, chr11: 2492629) downstream of the splice-site variant
(Figure S4).
Overall, these data demonstrate defective expression of the
KCNQ1 transcript downstream of the splice-site variant and
complete absence of methylation at IC2 on the maternal
chromosome, suggesting that premature transcription termi-
nation upstream of IC2 did not allow to properly establish the
methylation imprint in the germline of the proband’s mother
leading to an imprinting error in the embryo.
LQTS in a BWS family with a 160-kb KCNQ1 duplication and
complete IC2 LOM
To identify asymptomatic cases of LQTS in an Italian BWS
cohort, ECG was evaluated in 24 patients with IC2 LOM. A
prolonged QTc value diagnostic of LQTS was found in only
one patient (patient 24 in Table S1). The proband (III-8 in
Fig. 4a) was part of a previously described family, including
several other individuals with BWS features, and in which
segregates a 160-kb KCNQ1 duplication (Fig. 4a, b, and
Chiesa et al.16). Two apparently healthy children (III-4 and
III-5) of II-3, not born at the time of the first study, were
added to the present study. The duplication was confirmed in
III-5, but excluded in III-4 (Figure S6). Further clinical
examination of the family showed borderline prolonged QTc
values in all maternal and paternal duplication carriers who
accepted the ECG exam including III-5 (Fig. 4a). This
demonstrates that LQTS cosegregates with the duplication on
both maternal and paternal transmission, while BWS does it
only on maternal transmission. Importantly, the original
study also showed that maternal transmission of the
duplication was associated with complete loss of DNA
methylation of the duplicated IC2, leading to activation of a
truncated form of KCNQ1OT1 and silencing of CDKN1C.16
To test if the methylation defect was extended to other ICRs
or restricted to IC2 in this family, five loci that are frequently
affected in MLID17 were analyzed. The methylation values of
all tested ICRs were comparable with the values of healthy
individuals, in II-3, II-5, III-5, and III-8, indicating that the
epigenetic defect was restricted to IC2 (Table S4).
These results demonstrate that a pathogenic variant within
KCNQ1 segregates with BWS and complete IC2 LOM on
maternal transmission and with LQTS on both maternal and
paternal transmission.
DISCUSSION
In rare cases, DNA methylation defects in BWS occur
secondary to genetic variants acting in cis or in trans and
are associated with higher recurrence risk.17–20 The identifica-
tion of these genetic variants is therefore important for genetic
Fig. 1 Characterization of a 120–kb deletion abolishing the KCNQ1 promoter. a Pedigree of family 1. The symbol partitioned in two halves with
different filling indicate the proband (II-1) affected by Beckwith–Wiedemann syndrome (BWS) and long QT syndrome 1 (LQTS1). b DNA methylation analysis
of IC2 and IC1 by methylation-specific MLPA (MS-MLPA). The histogram shows DNA methylation levels of the proband (II-1) and controls. Numbers indicate
the length (nt) of the probes according to the manufacturer's instructions (ME-030, MRC-Holland); 355 is a digestion control probe. c DNA methylation
analysis of IC2 and IC1 by pyrosequencing. Each dot represents the methylation value of a single CpG. Ctrl 1 and Ctrl 2 are unrelated healthy individuals;
BWS 1 and BWS 2, two further BWS patients with IC2 loss of methylation (LOM). d Copy-number (CN) analysis of KCNQ1 exons in the trio by MLPA. The
histograms represent the normalized CN detected with 18 MLPA probes (SALSA MLPA 144 Long QT probemix version A2) hybridizing within the KCNQ1
exons. Exon numbering is according to Lee et al.8 e Segregation in the trio of two single-nucleotide variants (SNVs) (SNV2: rs2023818 and SNV3: rs800336)
located in the deleted region, as determined by Sanger sequencing, and demonstrating the maternal origin of the deletion. A schematic diagram of the
KCNQ1 locus is reported. KCNQ1 (represented by a thin black bar) and KCNQ1OT1 (represented by a thicker blue bar) are transcribed on opposite strands.
The pink rectangle highlights the region involved in the deletion. The vertical red lines indicate the location of SNVs 2 and 3 typed for segregation analysis
and SNVs 10 and 11 reported in 1f. f Allele-specific expression analysis obtained by typing SNV10: rs2283168 A/G and SNV11: rs2283169 on total RNA
from blood leukocytes of the proband. SNV10 and SNV11 are located between exon 1 and exon 2, downstream of the deletion and are present in
heterozygosity in the proband. The nucleotides of the single-nucleotide polymorphisms (SNPs) determined by Sanger sequencing in DNA and RNA are
reported below each electropherogram. Note the monoallelic expression of KCNQ1.
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Fig. 2 Clinical and molecular features associated with a splice-site variant in the 5’ donor site of KCNQ1 first intron. a Pedigree of the family. The
proband (III-1) affected by Beckwith–Wiedemann syndrome (BWS) and long QT syndrome 1 (LQTS1) is indicated as in Fig. 1. The symbol with stripes
indicates the LQTS1 condition affecting the proband’s mother (II-2), who is a carrier of the splice-site variant. The symbol with a dot in the middle indicates
the silent carrier of the splice-site variant. Black triangle: male fetus with large omphalocele, demised in utero at 5 months of gestation. White triangles:
spontaneous miscarriages. III-4: Stillborn (SB) twin. Asterisks: individuals unavailable for molecular analysis. b Methylation analysis of IC2 and IC1, as
determined by pyrosequencing. Each dot represents the methylation value of a CpG. Ctrl: unrelated healthy individual. c Electropherogram showing the
novel variant (KCNQ1-ENST00000155840: c.386+1G>C [IVS1+1G>C], GRCh37/hg19 chr11: 2,466,715) located at the donor splice site of the first intron
of KCNQ1. The splice-site variant was found in heterozygosity in III-1, II-2, and I-1, but was absent in III-2 and I-2.
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counseling. However, identifying variants associated with IC2
LOM in cis is challenging, because of the large extension of
the centromeric 11p15.5 imprinted domain. By looking for
the presence of LQTS features within three BWS cohorts, we
identified three cases in which complete IC2 LOM occurs
secondary to cis-acting DNA variants in the KCNQ1 gene. In
all three cases, the genetic variants cosegregate with BWS on
maternal transmission and in at least two cases were
demonstrated to affect KCNQ1 transcription upstream of
IC2, suggesting that lack of transcription across this ICR leads
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to LOM, likely because of defective de novo methylation in
oocytes (Fig. 5).
LQTS and BWS with complete IC2 LOM associated with a
transcription defect of KCNQ1
The pathogenic variant found in the proband of family 1
removes the promoter and causes loss of both main KCNQ1
transcript isoforms on the maternal chromosome. The
complete absence of IC2 methylation in the proband indicates
that this epimutation arose as a consequence of defective
imprint establishment in the maternal germline. Consistent
with the role of Kcnq1 transcription in de novo IC2
methylation demonstrated in mouse,11 it is possible that this
imprinting defect derived from lack of KCNQ1 transcription
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in the oocyte. Loss of expression of one allele also results in
KCNQ1 haploinsufficiency and this is the likely cause of
LQTS in this individual. A deletion of similar extension on
chromosome 11p15 but associated with more complex
rearrangements has been recently described in a family with
multiple offspring with large omphalocele and complete IC2
LOM, which was incompatible with life.21 Similarly to
our case, this epimutation could be originated as a
consequence of defective KCNQ1 transcription and imprint
establishment.
LQTS and BWS with complete IC2 LOM associated with a
splice-site variant and premature termination of KCNQ1
transcript
Although several KCNQ1 splice-site variants have been identified
in LQTS22,23 (https://www.ensembl.org/Homo_sapiens/
Transcript/ProtVariations?db=core;g=ENSG00000053918;r=11:
2444684-2849110;t=ENST00000155840), our case 2 splicing
defect is the only one, to our knowledge, that has ever been
reported as associated with BWS. Often, abnormal splicing leads
to premature translation termination and messenger RNA
(mRNA) degradation by nonsense-mediated decay.24 However,
in the case of this splice-site variant, the twofold reduction and
the shift from two alleles to one allele in KCNQ1 expression
between the variant and a cluster of poly-A sites in intron
1 suggests a rather different mechanism, in which premature
transcription termination occurs in the KCNQ1 gene.
It is known that pre-mRNA's processing of eukaryotic genes
including splicing occurs cotranscriptionally.25 Several studies
have demonstrated that the splicing apparatus stimulates
transcription elongation through direct interaction with
elongation factors, suggesting that checkpoint mechanisms
ensure that only spliced transcripts are efficiently elon-
gated.26–28 Consistent with this hypothesis, knockdown of
U1 small nuclear ribonucleoprotein (snRNP) results, in
addition to splicing inhibition, in premature cleavage of
pre-mRNAs at cryptic polyadenylation signals in introns
located near the transcription start site of large genes.29–31
Intriguingly, in our case, the KCNQ1 splice-site variant alters
the 5’ splice site that normally pairs with the U1 snRNP,
suggesting that weakening this binding causes termination,
cleavage, and polyadenylation of the promoter 1a–derived
transcript upstream of IC2. Because 1a is an active KCNQ1
promoter in most fetal tissues,8 we expect that the exon
1a–derived transcript is prematurely terminated in oocytes
and this possibly results in failure of IC2 methylation
establishment in the maternal germline. Further experiments,
such as 3’-RACE, may be performed in the future to more
precisely determine the transcription termination of KCNQ1
relative to the cryptic poly-A addition site in intron 1, in the
present case.
In family 2, the BWS phenotype is associated with the
splice-site variant on maternal transmission, while LQTS
occurs on both maternal and paternal transmission. This is
consistent with the maternal methylation of IC2 and the lack
of imprinting of KCNQ1 in heart. KCNQ1 haploinsufficiency
is expected from incomplete elongation of the transcript
caused by the splice-site variant. Consistent with our findings,
exon 1a pathogenic variants have been reported associated
with LQTS.22,32 The absence of BWS features including
normal IC2 methylation in the maternal grandfather suggests
that the variant is present on his paternal chromosome, while
the absence of LQTS in this individual is probably explained
by incomplete penetrance of the variant.33 The multiple
miscarriages, including one fetus with a large omphalocele,
are reminiscent of what was described in a family with
KCNQ1 deletion,21 and suggest that the proband’s aunt is a
silent carrier of the splice-site variant and that the phenotypes
of the progeny are the result of combined KCNQ1
haploinsufficiency and IC2 imprinting defect.
LQTS and BWS with complete IC2 LOM associated with a
160-kb KCNQ1 duplication
The proband of family 3 scored positive for prolonged QTc
value in an ECG screening offered to all BWS patients with
IC2 LOM of an Italian cohort (Table S1). Following this result,
three further members of this family were found to have
prolonged QTc value. All these individuals carry a previously
described 160-kb internal KCNQ1 duplication segregating
with BWS with IC2 LOM on maternal transmission.16 We
Fig. 3 Effect of the splice-site variant on KCNQ1 expression. (a) Transcription profile of KCNQ1 in III-1 and III-2 obtained by RNAseq on total RNA from
blood leukocytes. Top: screenshot from University of California–Santa Cruz (UCSC) Genome Browser showing the RNA transcribed from the positive (blue)
and negative (red) strands of the KCNQ1 locus. A track showing the location of AATAAA poly-A addition sites is reported below the RNA tracks. The peak of
reads on both strands in the middle of the gene (indicated by an asterisk) corresponds to an L1 repeat. Bottom: zoom in of the first 5’ 20 kb of KCNQ1. (b)
Observed increased expression of the most 5’ 10 kb of KCNQ1 in the proband (III-1) compared with her sister (III-2). Expression profile of the most 5’ 20 kb
(2466670-2486670) represented as normalized read count partitioned in windows of 1 kb (bar plots on the left) or normalized read count distribution in two
windows of 10 kb (box plots on the right) of III-1 and III-2. Y-axis values in bar plots are absolute counts in millions normalized by the number of uniquely
mapped reads. Box plots show a statistically significant enrichment of the coverage in the first 10 kb (2466670-2476670) of III-1 compared with III-2, but
similar coverages in the following 10 kb (2476670-2486670). (c) Allele-specific expression analysis of KCNQ1 in III-1, II-2, I-1, and III-2 of family 2 and an
unrelated Beckwith–Wiedemann syndrome (BWS) case with IC2 loss of methylation (LOM), analyzed as in Fig. 1f. A schematic diagram of KCNQ1 is
reported at the top to indicate the positions of the analyzed single-nucleotide variants (SNVs) (red vertical lines). SNV codes are listed in Table S2. The
electropherograms are organized in three panels corresponding to SNVs located in different parts of the KCNQ1 gene. The numbers in parentheses at the
left of the electropherograms represent the SNVs analyzed in each individual. The splice-site variant described in Fig. 2c is indicated by an asterisk. (d) Allele-
specific expression analysis of KCNQ1 to determine the parental origin of the transcribed allele in III-1. The typed SNV (SNV12= rs7942590 G/C) falls in the
part of the KCNQ1 gene that is expressed from only one allele. The boxed G represents the only allele present in the RNA of III-1.
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now find that this pathogenic variant also causes overt LQTS
or prolonged QTc value upon either maternal and paternal
transmission. Unfortunately, the lack of informative SNVs in
the 3’ part of KCNQ1 prevented investigation of allelic
expression in this family. However, we originally demon-
strated that one of the duplicated copies of IC2 is completely
nonmethylated on the maternal chromosome and that the
duplication is inverted in cis (Fig. 4b and Chiesa et al.16).
Here, we propose that KCNQ1 transcription is arrested before
reaching the duplicated IC2, because of the formation of a
stem-and-loop secondary structure of the transcript caused by
the inverted duplication and this in turn causes a failure of
imprint establishment in the maternal germline, similarly to
families 1 and 2 (Fig. 4). Indeed, stem-and-loop-dependent
mechanisms of transcription termination have been described
in mammals.34 Further studies are needed, however, to
directly demonstrate the role of this secondary structure in
transcription termination of KCNQ1 in the present case.
Interestingly, a case of BWS associated with a maternally
inherited KCNQ1 exon1c-1 duplication and complete IC2
LOM, which could also be caused by premature transcription
termination, has been reported by Demars et al.35
This is the first case of LQTS associated with a KCNQ1
duplication. The cardiac phenotype may be caused by either
(1) truncated KCNQ1 protein lacking the amino acids
encoded by last exon; or (2) degradation of the transcript
lacking the normal poly-A signal. Consistent with the first
mechanism, a truncating pathogenic variant close to the last
KCNQ1 exon has been reported associated with LQTS36
(https://www.ensembl.org/Homo_sapiens/Transcript/Prot
Variations?db=core;g=ENSG00000053918;r=11:2444684-
2849110;t=ENST00000155840).
LQTS in BWS patients with IC2 LOM
Congenital disorders of the heart rhythm, such as LQTS, have
been rarely reported in BWS and generally associated with
maternal chromosome 11p15 rearrangements.37,38 In one of
these cases,38 the proband carries a translocation with a
breakpoint between KCNQ1 exons 2 and 10 and shows IC2
LOM, which could indeed be caused by defective transcrip-
tion across IC2. In this study, we identified three cases with
combined BWS and LQTS related to three different genetic/
genomic lesions leading to a common epigenotype derange-
ment. Although further studies are needed to clarify the exact
I
1* 2* 3* 4 5* 6*
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a
Fig. 4 Segregation of long QT syndrome (LQTS) and Beckwith–Wiedemann syndrome (BWS) phenotypes in a family with a 160-kb KCNQ1
duplication. a Pedigree of family 3, modified from Chiesa et al.16 The proband (III-8) affected by both BWS and LQTS1 is indicated as in Fig. 1. The gray
stripes in II-3, II-5, and III-5 indicate borderline prolonged QTc values. Asterisks: family members unavailable for molecular analysis. b Schematic repre-
sentation of the 160-kb KCNQ1 duplication. The light blue rectangle highlights the region involved in the duplication. Breakpoint 1 is telomeric; breakpoint
2, centromeric. The position of the inverted duplication in the centromeric breakpoint and the the stem-and-loop structure in the KCNQ1 transcript are
proposed to explain the molecular data.
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prevalence, the ECG screening performed in the Italian cohort
indicates a low incidence of LQTS among the BWS patients
with IC2 LOM, confirming the relatively rare overlap of these
two diseases. The BWS guidelines recommend that physicians
should be aware of the increased prevalence of cardiac
anomalies in children with BWS and indicate annual
evaluation and electrocardiogram in patients with genomic
rearrangements involving the IC2 region. However, because
of the incomplete penetrance of KCNQ1 variants and the
associated high risk of major cardiac events in adult age,23,33
an ECG (and if positive further KCNQ1 analysis) should be
performed in all BWS patients with IC2 LOM.
In summary, this study proposes a new molecular
mechanism, in which two diseases, LQTS and BWS, share
the same genetic defect.39,40 We demonstrate that, by
affecting KCNQ1 transcription, genetic variants may result
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Fig. 5 Model of how a single genetic KCNQ1 variant may determine both long QT syndrome (LQTS) and Beckwith–Wiedemann syndrome
(BWS). In the female germline, the KCNQ1 promoter drives a transcript across IC2, which is required for de novo methylation of this imprinting control
region (ICR). Differential IC2 methylation regulates KCNQ1OT1 and CDKN1C imprinting in somatic cells. Genetic variants causing loss or premature
termination of KCNQ1 transcription result in (1) BWS due to defective IC2 methylation establishment, biallelic KCNQ1OT1 expression, and CDKN1C
silencing, and LQTS due to KCNQ1 haploinsufficiency, on maternal transmission; (2) LQTS due to KCNQ1 haploinsufficiency on paternal transmission. Active
promoters and transcription orientation are indicated by bent green arrows. Methylated IC2 is indicated by filled lollipop, unmethylated IC2 by open lollipop.
The KCNQ1 transcript is depicted as a pink curved line. The dashed curved line indicates the paternal KCNQ1 transcript that is expressed in heart and adult
tissues and imprinted in embryo. Genetic variants causing loss of KCNQ1 transcription are indicated by a red cross. The KCNQ1 gene is represented
nonimprinted in somatic cells, according to the results obtained in blood leukocytes.
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in KCNQ1 haploinsufficiency and LQTS, and at the same
time we suggest these lesions may interfere with de novo
IC2 methylation in the oocyte and cause BWS later in
development. As consequence of the differential imprinting
status of KCNQ1OT1 and KCNQ1, BWS occurs only
on maternal transmission of the variants while no
parent-of-origin-dependent effect is observed with LQTS
(Fig. 5).
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